vs
Side-by-side financial comparison of Better Home & Finance Holding Co (BETR) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $44.3M, roughly 1.3× Better Home & Finance Holding Co). RHYTHM PHARMACEUTICALS, INC. runs the higher net margin — -83.0% vs -3349.0%, a 3266.0% gap on every dollar of revenue. On growth, Better Home & Finance Holding Co posted the faster year-over-year revenue change (77.4% vs 36.9%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 41.1%).
Bajaj Finance Limited (BFL) is an Indian deposit-taking non-banking financial company (NBFC-UL) headquartered in Pune. It has 110.64 million customers and holds assets under management worth ₹462,250 crore (US$55 billion), as of September 2025.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
BETR vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.3M | $57.3M |
| Net Profit | $-39.9M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | -3376.8% | -82.2% |
| Net Margin | -3349.0% | -83.0% |
| Revenue YoY | 77.4% | 36.9% |
| Net Profit YoY | 32.6% | -9.6% |
| EPS (diluted) | $-2.52 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.3M | $57.3M | ||
| Q3 25 | $43.9M | $51.3M | ||
| Q2 25 | $44.1M | $48.5M | ||
| Q1 25 | $32.6M | $32.7M | ||
| Q4 24 | $25.0M | $41.8M | ||
| Q3 24 | $29.0M | $33.3M | ||
| Q2 24 | $32.3M | $29.1M | ||
| Q1 24 | $22.3M | $26.0M |
| Q4 25 | $-39.9M | $-47.5M | ||
| Q3 25 | $-39.1M | $-52.9M | ||
| Q2 25 | $-36.3M | $-46.6M | ||
| Q1 25 | $-50.6M | $-49.5M | ||
| Q4 24 | $-59.2M | $-43.3M | ||
| Q3 24 | $-54.2M | $-43.6M | ||
| Q2 24 | $-41.4M | $-32.3M | ||
| Q1 24 | $-51.5M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | -3376.8% | -82.2% | ||
| Q3 25 | -88.9% | -102.6% | ||
| Q2 25 | -81.9% | -93.4% | ||
| Q1 25 | -154.9% | -143.7% | ||
| Q4 24 | -1428.3% | -98.6% | ||
| Q3 24 | -186.5% | -132.0% | ||
| Q2 24 | -127.6% | -139.2% | ||
| Q1 24 | -230.8% | -538.7% |
| Q4 25 | -3349.0% | -83.0% | ||
| Q3 25 | -89.2% | -103.1% | ||
| Q2 25 | -82.2% | -96.1% | ||
| Q1 25 | -155.3% | -151.4% | ||
| Q4 24 | -1437.5% | -103.6% | ||
| Q3 24 | -187.0% | -131.2% | ||
| Q2 24 | -128.2% | -110.9% | ||
| Q1 24 | -231.4% | -544.4% |
| Q4 25 | $-2.52 | $-0.73 | ||
| Q3 25 | $-2.56 | $-0.82 | ||
| Q2 25 | $-2.39 | $-0.75 | ||
| Q1 25 | $-3.33 | $-0.81 | ||
| Q4 24 | $-3.92 | $-0.71 | ||
| Q3 24 | $-3.58 | $-0.73 | ||
| Q2 24 | $-2.74 | $-0.55 | ||
| Q1 24 | $-3.41 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $203.4M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $37.2M | $139.1M |
| Total Assets | $1.5B | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $203.4M | $388.9M | ||
| Q3 25 | $205.8M | $416.1M | ||
| Q2 25 | $221.5M | $291.0M | ||
| Q1 25 | $228.0M | $314.5M | ||
| Q4 24 | $264.9M | $320.6M | ||
| Q3 24 | $262.1M | $298.4M | ||
| Q2 24 | $378.8M | $319.1M | ||
| Q1 24 | $482.6M | $201.2M |
| Q4 25 | $37.2M | $139.1M | ||
| Q3 25 | $41.9M | $148.8M | ||
| Q2 25 | $76.6M | $-11.9M | ||
| Q1 25 | $-102.1M | $18.9M | ||
| Q4 24 | $-58.2M | $21.7M | ||
| Q3 24 | $388.0K | $11.2M | ||
| Q2 24 | $44.9M | $39.3M | ||
| Q1 24 | $76.3M | $61.6M |
| Q4 25 | $1.5B | $480.2M | ||
| Q3 25 | $1.4B | $506.9M | ||
| Q2 25 | $1.2B | $372.7M | ||
| Q1 25 | $1.0B | $386.7M | ||
| Q4 24 | $913.1M | $392.3M | ||
| Q3 24 | $845.2M | $363.6M | ||
| Q2 24 | $957.9M | $381.8M | ||
| Q1 24 | $841.6M | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-166.6M | $-25.4M |
| Free Cash FlowOCF − Capex | $-167.8M | — |
| FCF MarginFCF / Revenue | -378.6% | — |
| Capex IntensityCapex / Revenue | 2.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-277.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-166.6M | $-25.4M | ||
| Q3 25 | $4.2M | $-26.6M | ||
| Q2 25 | $-56.3M | $-23.3M | ||
| Q1 25 | $-57.2M | $-40.4M | ||
| Q4 24 | $-380.0M | $-18.8M | ||
| Q3 24 | $-10.6M | $-25.2M | ||
| Q2 24 | $-220.6M | $-29.1M | ||
| Q1 24 | $-42.8M | $-40.7M |
| Q4 25 | $-167.8M | — | ||
| Q3 25 | $4.0M | — | ||
| Q2 25 | $-56.7M | — | ||
| Q1 25 | $-57.4M | — | ||
| Q4 24 | $-383.4M | — | ||
| Q3 24 | $-11.7M | — | ||
| Q2 24 | $-221.8M | — | ||
| Q1 24 | $-43.3M | — |
| Q4 25 | -378.6% | — | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | -128.5% | — | ||
| Q1 25 | -176.3% | — | ||
| Q4 24 | -1534.6% | — | ||
| Q3 24 | -40.5% | — | ||
| Q2 24 | -687.6% | — | ||
| Q1 24 | -194.5% | — |
| Q4 25 | 2.7% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 2.1% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
